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Experimental and clinical evidence suggests that angiotensin II (AII) participates in renal development. Renal AII content is
several-fold higher in newborn rats and mice than in adult animals. AII receptors are also expressed in higher amounts in the
kidneys of newborn rats. The kidneys of fetuses whose mother received a type 1 AII receptor (AT1) antagonist during gestation
present several morphological alterations. Mutations in genes that encode components of the renin-angiotensin system are
associated with autosomal recessive renal tubular dysgenesis. Morphological changes were detected in the kidneys of 3-week-
old angiotensin-deficient mice. Mitogen-activated protein kinases (MAPKs) are important mediators that transduce extracellular
stimuli to intracellular responses. The MAPK family comprises three major subgroups, namely extracellular signal-regulated
protein kinase (ERK), c-jun N-terminal kinases (JNK), and p38 MAPK (p38). Important events in renal growth during
nephrogenesis such as cellular proliferation and differentiation accompanied by apoptosis on a large scale can be mediated by
MAPK pathways. A decrease in glomerulus number was observed in embryos cultured for 48 and 120 h with ERK or p38
inhibitors. Many effects of AII are mediated by MAPK pathways. Treatment with losartan during lactation provoked changes in
renal function and structure associated with alterations in AT1 and type 2 AII (AT2) receptors and p-JNK and p-p38 expression
in the kidney. Several studies have shown that AII and MAPKs play an important role in renal development. However, the
relationship between the effects of AII and MAPK activation on renal development is still unclear.
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Introduction
In humans, the branching ureteric duct reaches the
outer cortex approximately 12 weeks before term. New
nephron formation ceases between the 28th and 36th
gestational week (1). The nephrogenesis of rats begins on
embryonic day 12 and is completed between 10 and 15
days after birth (1,2). Four different stages of glomerular
development have been defined: a) vesicle, b) S-shaped
body, c) developing capillary loop, and d) maturing stages
(2). One- and 7-day-old rats present glomeruli in different
stages of differentiation, while 15- and 30-day-old rats
present glomeruli in the final stage of development.
Increases in fibronectin, α-smooth muscle actin (α-SM-
actin), proliferating cell nuclear antigen (PCNA), phospho-
extracellular signal-regulated protein kinase (p-ERK), and
angiotensin II (AII) expression are observed in the renal
cortex of 1- and 7-day-old rats, followed by a decrease
during renal development (3). The activation of these cells
may be due at least in part to an increase in renal AII and
mitogen-activated protein kinase (MAPK) content in the
renal cortex (Figure 1). Fibronectin is one of the most
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important components of the extracellular matrix (ECM).
Formation of the ECM represents a key event in kidney cell
differentiation (4,5). Fibronectin is a glycoprotein that can
interact with some proteins from the cell or ECM, inducing
changes in cellular migration and adhesion (5). AII stimu-
lates mesangial cells to produce various ECM components
in cell culture studies (6), and also promotes cell prolifera-
tion and differentiation (7). It has also been shown that
human fetal mesangial cells express α-SM-actin (8,9) and
that large-scale cell proliferation occurs during kidney de-
velopment (10). Up-regulated α-SM-actin synthesis by
mesangial cells is frequently associated with increased
cell proliferation and ECM production (11).
ERK has been related to cell proliferation and differen-
tiation and is also expressed at higher intensity in 1-day-
old rats (12,13). Several effects of AII are mediated through
MAPK pathways (14,15). Kubo et al. (14) reported that AII
and endothelin provoke increased MAPK activity in cul-
tures of vascular smooth muscle cells, and that this activity
is inhibited by losartan and by an endothelin receptor
antagonist. In addition, evidence shows that MAPK ex-
pression in the developing kidneys is modulated by angio-
tensin-converting enzyme, and that c-Jun N-terminal ki-
nases (JNKs), as well as AII-related intracellular signaling
pathways of renal apoptosis in the developing kidney can
be mediated by the p38 MAPK pathway (15). Taken to-
gether, the results of all these studies show that AII plays
an important role in renal development and that many
effects of this peptide, such as cell proliferation and differ-
entiation as well as apoptosis, can be mediated by the
MAPK pathways.
Evidence for a role of AII in kidney
development
Clinical and experimental evidence shows that the
renin-angiotensin system participates in renal develop-
ment (16–22). Greater angiotensinogen expression has
been observed in the rat kidney during
late gestation and the newborn period
than in adult kidney. Renin mRNA was
detected after embryonic day 17 and
was higher in fetuses on embryonic
day 20 and in newborns than in adult
rats (17,18). Renal AII content is sev-
eral-fold higher in newborn rats and
mice than in their adult counterparts.
AII receptors are also expressed to a
greater extent in newborn rats (19).
The mRNA for the type 1 AII receptor
(AT1) has been detected in the renal
glomeruli of newborn rats during cell
proliferation and differentiation (20).
Renal expression of the type 2 AII re-
ceptor (AT2) increases during fetal life
and decreases after birth (20), sug-
gesting that AII modulates the growth
of various cell types and tissues (21,22).
Mutations in genes that encode
components of the renin-angiotensin
system are associated with autosomal
recessive renal tubular dysgenesis (23).
Kidneys from fetuses with tubular dys-
genesis show absence of tubule differ-
entiation and marked thickening of ar-
terial walls. These fetuses also present
anuria, oligohydramnios and skull ossi-
fication defects. The kidney of 3-week-
old angiotensin-deficient mice showed
pelvic dilation with an atrophic papilla,
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Figure 1. Immunolocalization of angiotensin II (A and B), phospho-extracellular signal-
regulated protein kinase (p-ERK; C and D), phospho-c-jun N-terminal kinase (p-JNK; E
and F) (arrows) in the renal cortex of rats at 1 (A, C, and E) and 30 days (B, D, and F) of
age (scale bars = 20 mm; original magnification 250X). Note that the reactions are more
intense in A and C than in B and D.
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medial hyperplasia of the interlobular artery and afferent
arterioles, glomeruli with axial mesangial expansion, re-
duced glomerular area, patchy fibrosis, mononuclear infil-
trate in the interstitium, as well as dilated tubules in the
outer medulla with interstitial fibrosis around the dilated
tubules (24). In conclusion, several lines of clinical and
experimental evidence indicate that AII has an important
role in pre- and postnatal renal development.
Evidence for the role of MAPK in kidney
development
Many effects of AII are mediated through MAPK path-
ways (14,15,25). AII converting enzyme modulates the
expression of components of the MAPK family in kidney
from neonatal rats (15). Kumar et al. (25) suggested that
the activation of p38 and JNK MAPKs was linked to AII
signaling and demonstrated that such activation is associ-
ated with acute ischemic-reperfusion injury and may be
linked, in part, to AT2 stimulation. The authors showed that
the improvement in left ventricular function induced by AT2
blockade was associated with a nor-
malized expression of p-JNK-1 and a
slight increase in p38 expression.
Immunoblot analyses of kidney ho-
mogenates, as well as immunohisto-
chemical studies, have indicated that
ERK and p38 MAPKs are predomi-
nantly expressed in the developing kid-
ney, the highest levels being observed
in the embryo (10). The role of JNK
MAPK in embryogenesis has been in-
vestigated, and it has been shown that
the loss of the MKK4 gene, a JNK
activator, results in embryonic death
(26). A decrease in glomerulus number
was observed in 15-day-old embryos
cultured for 48 and 120 h with ERK or
p38 inhibitors (27). Choi et al. (15) re-
ported that the treatment of newborn
rats with enalapril for 7 days increased
JNK-2 and p38 MAPK expression in
the kidney, and that these increases
were temporally associated with higher
numbers of apoptotic cells. However,
the authors did not find any alteration in
renal p-ERK expression in those ani-
mals. Nevertheless, it has been previ-
ously shown that p-ERK is related to
cell proliferation and differentiation,
while p-JNK and p38 MAPKs are in-
volved in apoptosis (28). Therefore, the activation of the
MAPK pathways by AII can result in apoptosis and cell
proliferation and differentiation that are important events in
renal development (Figure 2).
Renal development in offspring of dams
submitted to a high sodium diet during
pregnancy
It has been reported that a prenatal high salt diet
increases blood pressure and salt retention in spontane-
ously hypertensive rats (29). da Silva et al. (30) and Hazon
et al. (31) observed that adult offspring submitted to peri-
natal salt overload presented higher blood pressure, which
was associated with increased renal AII content and ab-
sence of plasma renin changes in response to higher salt
consumption (30). We observed a decrease in fibronectin,
α-SM-actin, PCNA, p-ERK MAPK, AT1, and AII expression
in the renal cortex of 1-day-old pups from dams subjected
to sodium intake compared to same-age control rats (3,13).
Therefore, there is a temporal association between the
Figure 2. Schematic representation of angiotensin II (AII)-induced mitogen-activated
protein kinase (MAPK) activation. AII acts through the type 1 AII (AT1) and type 2 AII
(AT2) membrane receptors initiating intracellular signaling, with MAPK phosphorylation
and activation of transcription factors in the nucleus, resulting in mRNA production for
mediators of apoptosis, cellular differentiation and proliferation. GTPase = guanosine
triphosphatase; MAPKKK = MAPKK kinase; MAPKK = MAPK kinase; ERK = extracel-
lular signal-regulated protein kinase; JNK = c-jun N-terminal kinase; p38 = p38 MAPK.
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reduction of AII and p-ERK MAPK expression and the
decrease of α-SM-actin, fibronectin and PCNA expression
in the renal cortex. There was an increase in p-p38 and p-
JNK MAPK expression in 30-day-old pups of dams that
received sodium intake (13).
Thirty-day-old rats from dams that received saline also
presented higher systolic blood pressure and a decrease
in glomerular filtration rate (3). We also found increased
glomerulosclerosis and tubulointerstitial lesions in the re-
nal cortex of 120-day-old offspring from dams subjected to
an increase in saline intake compared to the same age
control rats (32). These data show that sodium intake
during gestation and lactation in rats leads to changes in
the renal expression of AII receptors and MAPK in the pups
that result in higher blood pressure and structural changes
in the kidney of adult offspring.
Renal development in offspring of mothers
that received angiotensin II antagonists
Human fetal kidneys from mothers that received an AT1
antagonist during gestation presented poorly developed
tubules, increased mesenchymal tissue, reduced num-
bers of proximal tubules, abnormal arterial and arteriolar
walls, poorly developed vasa recta, and hyperplastic juxta-
glomerular apparatus (33). Spence et al. (34,35) have
shown in experimental studies that maternal treatment
with losartan during late gestation and lactation is associ-
ated with lower pup body weights and higher pup mortality
rates during the preweaning/postweaning periods, as well
as irreversible histopathologic renal abnormalities in the
F1 generation. Morphological renal findings, such as dila-
tion of the renal pelvis, edema of the renal papilla, medial
hypertrophy of intracortical arterioles, chronic renal inflam-
mation, and irregular scarring of the renal parenchyma,
have been described in rats. Akil et al. (36), using losartan
to block AT1 in pregnant rats, observed that the fetuses
presented growth inhibition, delayed nephron maturation,
increased TGF-β immunoreactivity and glomerular basal
membrane thickness associated with apoptosis in devel-
oping tubular structures during the early period of nephro-
genesis. It was also reported that the fibrogenic effects of
AII were mediated by AT2 receptors whose expression was
increased in injured tissues and organs undergoing re-
modeling.
Neonatal rats treated with an angiotensin-converting
enzyme inhibitor presented persistent and irreversible his-
topathological renal abnormalities in adult life (37). These
abnormalities mainly consisted of cortical tubulointerstitial
inflammation, various degrees of papillary atrophy and
pelvic dilation.
Chen et al. (38) reported in rat pups treated for 2 days
with losartan down-regulation of genes encoding cytoskel-
etal and ECM components, resulting in malformation of the
ECM and dysfunction of cell-cell and cell-matrix interac-
tions. Machado et al. (39) observed that rats that received
losartan during lactation presented albuminuria and alter-
ations in renal structure in adult life that were related to the
presence of an inflammatory infiltrate in the renal cortex.
We observed that the 30-day-old pups from dams treated
with losartan during lactation presented increased AT2, p-
JNK and p-p38 expression in the kidneys and higher
numbers of TUNEL (apoptosis) and PCNA-positive cells in
the renal cortex (40). Albuminuria, decreased glomerular
filtration rate as well as tubulointerstitial alterations and
decreased glomerular area were also found in 30-day-old
offspring from losartan-treated dams. Taken together, these
data show that treatment with losartan during lactation can
provoke changes in renal function and structure in rats
associated with alterations in AT1, AT2, p-JNK and p-p38
expression in the renal cortex. However, the effects of AII
on MAPK activation in the kidney of pups that received
losartan during lactation have not yet been clarified.
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